NASDAQ: RELIReliance Global Group Inc Stock
$1.22-0.03 (-2.4%)
Updated Jun 13, 2025
Reliance Global Group shares are... find out Why RELI Price Moved with a free WallStreetZen account
Why Price MovedRELI Price
$1.22
Fair Value Price
N/A
Market Cap
$3.63M
52 Week Low
$0.97
52 Week High
$18.53
P/E
-0.48x
P/B
1.39x
P/S
0.21x
PEG
N/A
Dividend Yield
N/A
Revenue
$14.83M
Earnings
$5.75M
Gross Margin
89.9%
Operating Margin
37.36%
Profit Margin
38.8%
Debt to Equity
5.43
Operating Cash Flow
$2M
Beta
0.7
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
RELI Overview
Reliance Global Group, Inc. engages in the acquisition and management of wholesale and retail insurance agencies in the United States. It provides healthcare and Medicare, personal and commercial, trucking, and employee benefits insurance products. The company was formerly known as Ethos Media Network, Inc. and changed its name to Reliance Global Group, Inc. in October 2018. Reliance Global Group, Inc. was incorporated in 2013 and is headquartered in Lakewood, New Jersey.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine RELI's potential to beat the market
- RELI doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Insurance
Industry Rating
B
RELI
RankedUnranked of 16
RankedUnranked of 16
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.02 | A | |
| $105.07 | B | |
| $2.16 | B |
Be the first to know about important RELI news, forecast changes, insider trades & much more!
RELI News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how RELI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RELI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RELI is good value based on its book value relative to its share price (1.39x), compared to the US Insurance Brokers industry average (5.57x)
P/B vs Industry Valuation
RELI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more RELI due diligence checks available for Premium users.
Valuation
RELI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.48x
Industry
-13.39x
Market
31.36x
RELI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.39x
Industry
5.57x
RELI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
RELI's financial health
Profit margin
Revenue
$4.2M
Net Income
-$1.7M
Profit Margin
-41%
RELI's Earnings (EBIT) of $5.54M... subscribe to Premium to read more.
Interest Coverage Financials
RELI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$16.8M
Liabilities
$14.2M
Debt to equity
5.43
RELI's short-term liabilities ($3.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RELI's long-term liabilities ($10.28M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RELI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$197.8k
Investing
-$14.9k
Financing
-$169.1k
RELI's operating cash flow ($2.04M)... subscribe to Premium to read more.
Debt Coverage Financials
RELI vs Insurance Stocks
Reliance Global Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.